Nektar Doses First Patients in Neuropathic Pain Study
Testing pharmacokinetics of novel pain-blocker
View ArticleAbbVie Begins Triple-Negative Breast Cancer Trial
Veliparib to be added to carboplatin in Ph III trial
View ArticleGalectin Drug in Early Test Against Melanoma
EACRI to test galectin-3 inhibitor with Yervoy in metastatic melanoma
View ArticleDosing Begins in Elite Bioequivalence Study
Camargo conducts abuse-deterrence study under 505(b)2
View ArticleMerrimack Initiates Phase I MM-398 Trial
To evaluate cyclophosphamide combination in pediatric tumors
View ArticleAmgen’s Phase III Evolocumab Trial Meets Endpoints
Reduces LDL-C in statin intolerant patients
View ArticlePfizer\'s Phase III ALO-02 Trial Meets Endpoint
Demonstrates statistically significant benefit
View Article
More Pages to Explore .....